Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-02

Clinical Trial Update: The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing semaglutide with caloric restriction in Type 2 Diabetes is currently recruiting. The study aims to evaluate the impact of these…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Type 2 Diabetes Mellitus (T2DM), Semaglutide | Phase 4 | Status: RECRUITING